M Siva

Dr. M Siva


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 January 2019 in Molecules
Verified
Journal Article
Open access
PDF file
MSM Siva
M Siva
YCYao Chen Chuang
Yao Chen Chuang
Leu-Wei LoLeu-Wei Lo
Leu-Wei Lo
Enthusiasm for photodynamic therapy (PDT) as a potential therapeutic intervention for cancer has increased exponentially in recent decades. Photodynamic therapy constitutes a clinically approved, minimally invasive treatment modality that uses a photosensitizer (light absorbing molecule) and light to kill cancer cells. The principle of PDT is, when irradiated with a light of a suitable wavelength, a photosensitizer absorbs the light energy and generates cytotoxic free radicals through various mechanisms. The overall efficiency of PDT depends on characteristics of activation light and in-situ dosimetry, including the choice of photosensitizer molecule, wavelength of the light, and tumor location and microenvironment, for instance, the use of two-photon laser or an X-ray irradiator as the light source increases tissue-penetration depth, enabling it to achieve deep PDT. In this mini-review, we discuss the various designs and strategies for single, two-photon, and X-ray-mediated PDT for improved clinical outcomes.

Verified
Journal Article
Open access
PDF file
MSM Siva
M Siva
YCYao Chen Chuang
Yao Chen Chuang
NCNai-Tzu Chen
Nai-Tzu Chen
Leu-Wei LoLeu-Wei Lo
Leu-Wei Lo
Biomedical imaging modalities in clinical practice have revolutionized oncology for several decades. State-of-the-art biomedical techniques allow visualizing both normal physiological and pathological architectures of the human body. The use of nanoparticles (NP) as contrast agents enabled visualization of refined contrast images with superior resolution, which assists clinicians in more accurate diagnoses and in planning appropriate therapy. These desirable features are due to the ability of NPs to carry high payloads (contrast agents or drugs), increased in vivo half-life, and disease-specific accumulation. We review the various NP-based interventions for treatments of deep-seated tumors, involving “seeing better” to precisely visualize early diagnosis and “going deeper” to activate selective therapeutics in situ.

2 June 2023 in Nanomaterials
Verified
Journal Article
Open access
PDF file
MSM Siva
M Siva
CCChia-Hui Chu
Chia-Hui Chu
YHYu Hsia
Yu Hsia
NCNai-Tzu Chen
Nai-Tzu Chen
MCMeng-Ting Cai
Meng-Ting Cai
Leu-Wei LoLeu-Wei Lo
Leu-Wei Lo
Although radiotherapy is one of the most important curative treatments for cancer, its clinical application is associated with undesired therapeutic effects on normal or healthy tissues. The use of targeted agents that can simultaneously achieve therapeutic and imaging functions could constitute a potential solution. Herein, we developed 2-deoxy-d-glucose (2DG)-labeled poly(ethylene glycol) (PEG) gold nanodots (2DG-PEG-AuD) as a tumor-targeted computed tomography (CT) contrast agent and radiosensitizer. The key advantages of the design are its biocompatibility and targeted AuD with excellent sensitivity in tumor detection via avid glucose metabolism. As a consequence, CT imaging with enhanced sensitivity and remarkable radiotherapeutic efficacy could be attained. Our synthesized AuD displayed linear enhancement of CT contrast as a function of its concentration. In addition, 2DG-PEG-AuD successfully demonstrated significant augmentation of CT contrast in both in vitro cell studies and in vivo tumor-bearing mouse models. In tumor-bearing mice, 2DG-PEG-AuD showed excellent radiosensitizing functions after intravenous injection. Results from this work indicate that 2DG-PEG-AuD could greatly potentiate theranostic capabilities by providing high-resolution anatomical and functional images in a single CT scan and therapeutic capability.

23 July 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
HZHannah J. Zhang
Hannah J. Zhang
TITristan Ide
Tristan Ide
MSM Siva
M Siva
LLLara Leoni
Lara Leoni
Jeffrey S. SourisJeffrey S. Souris
Jeffrey S. Souris
CCChin-Tu Chen
Chin-Tu Chen
Traditional photodynamic therapy (PDT) is often limited in its efficacy by insufficient light penetration, inefficient photosensitizer energy transfer, and inadequate target tissue oxygena tion. X-ray activated PDT (XPDT), using nanoparticle (NPs) photosensitizers comprised of euro pium-doped yttrium oxide cores encased within silica shells (Y2O3:Eu@SiO2), offers the potential of overcoming most of these limitations. Aimed at maximizing the generation of reactive oxygen spe cies (ROS), this study reports methodologies for investigation of the effects of synthesis conditions on the characteristics of Y2O3:Eu@SiO2 NP. Transmission electronic microscope (TEM) revealed that the NP core diameter was linearly, positively correlated with condensation time (R 2 = 0.7357, p < 0.05) and linearly, negatively correlated with urea concentration (R 2 = 0.958, p < 0.05). The addition of cetyltrimethylammonium bromide (CTAB) during core synthesis demonstrated enhanced parti cle dispersion. Silica coating via APTES-1 and TEOS-3 conditions resulted in Y2O3:Eu@SiO2 NPs that generated the highest ROS, with 8.7-fold and 8.9-fold increase respectively in relative fluorescence intensity at 8 Gy irradiation compared to a 5.2-fold increase in PBS under the same condition. In vivo evaluation using 18 F-fluorothymidine positron emission tomography ( 18 F-FLT PET) of mouse xeno grafts of a human prototypical cancer (ovarian) revealed a 55% reduction in tumor proliferation of radiation-sensitive CAOV3 tumors treated with Y2O3:Eu@SiO2 NPs compared to a 19% reduction in tumor proliferation of radiation-resistant SKOV3 tumors on the fourth day post-treatment. Taken together, these findings suggest Y2O3:Eu@SiO2 NPs can serve as effective photosensitizers for XPDT and their performance characteristics can be optimized by selecting synthesis conditions and param eters to deliver the desirable therapeutic effects, offering novel approaches to circumventing many of the limitations of conventional PDT in the treatment of cancer.